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The acute  phase  response  is  a  systemic reaction  to  inflammation or  tissue 
injury. It is characterized by complex changes that include fever, leukocytosis, 
increased muscle proteolysis, altered carbohydrate and trace metal metabolism, 
and a pronounced change in hepatic protein synthesis (1). Within several hours 
of an acute phase stimulus, the plasma concentrations of C-reactive protein and 
serum amyloid A (SAA) 1 are increased more than 100-fold. The concentrations 
of numerous serum glycoproteins are increased up to threefold (e.g. fibrinogen, 
haptoglobin, al-glycoprotein, al-antitrypsin, and several complement proteins), 
and the concentrations of a  small number of proteins are decreased (albumin, 
prealbumin, transferrin, ol2-HS-glycoprotein) (2). The mechanism by which injury 
at a distant site can effect changes in hepatic protein synthesis has been studied 
during  the  last  fifty years.  These  studies  have  suggested  that  a  circulating 
mediator, interleukin  1  (IL-1),  derived from mononuclear phagocytes, elicits 
changes in the serum protein pattern similar to those observed during an acute 
phase response (3-4). However, none of these studies established that IL-1 solely 
and directly effects these changes in hepatocyte protein synthesis. That is, the 
role of IL-1 was inferred from the effect of in vivo administration of preparations 
of IL-1  purified to  varying degrees,  and  from studies of primary hepatocyte 
cultures in which baseline (unstimulated) synthesis of acute phase proteins was 
rather high (5) or the IL-1 preparation was incompletely characterized. 
To  directly  address  these  issues  and  thus  to  permit  investigation  of  the 
mechanisms modulating hepatic protein synthesis by IL-1, we took advantage of 
two recent advances: (a)  The cloning of mouse IL-1  cDNA into an expression 
vector, thus making available large quantities of homogeneous preparations of 
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I L-1 synthesized as the product of a single gene (6) and (b) the isolation of cDNA 
specific for acute phase proteins as probes for assessing acute phase gene expres- 
sion (7-9). 
Accordingly, the effect of IL-1 on synthesis of quantitatively major (SAA) and 
minor (factor B) positive acute phase reactants, and on albumin, a negative acute 
phase reactant, was examined in vivo and in primary mouse hepatocyte cultures. 
A  dose-  and  time-dependent  increase  in  SAA  and  factor  B  synthesis,  and  a 
decrease  in  albumin  synthesis  was  induced  by recombinant-generated  murine 
and highly purified human IL-1  in primary mouse hepatocyte cultures. Regula- 
tion of these changes was pretranslational,  since changes in mRNA specific for 
SAA, factor B, and albumin were affected by both IL-! preparations.  A  similar 
pretranslational regulation of positive and negative acute phase protein synthesis 
was demonstrated in mice injected with recombinant-generated IL-1. 
Materials and Methods 
Mice.  Female and male C3H/HeJ and C3HeB/FeJ mice aged 6-12 wk were obtained 
from the Jackson Laboratories, Bar Harbor, ME. No significant sex differences have been 
observed in the acute phsae (SAA) response of C3H mice, although it is known that a 
higher baseline SAA concentration has been observed in untreated male mice (10). 
Primary Hepatocyte Cultures.  Mouse hepatocytes were isolated according to a previously 
described method (11-13). Briefly, the liver was perfused in situ with collagenase (Boeh- 
ringer Mannheim Diagnostics, Inc., Houston, TX) through the portal vein. Hepatocytes 
were separated from nonparenchymal cells by differential centrifugation, and the resulting 
contamination with Kupffer cells was always < 1% (14). The viability (as assessed by trypan 
blue exclusion) was 85-95%. Yields were 1.5-2.5 X 107 cells/liver. The cells were plated 
either on collagen (Sigma Chemical Co.,  St.  Louis, MO)-coated 24-well Linbro plates 
(Flow Laboratories, Inc., McLean, VI) at 105 cells/well, in 0.5 ml culture medium, or on 
collagen-coated six-well  Falcon  plates  (Becton Dickinson  &  Co.,  Oxnard,  CA)  at  106 
cell/well in  1.5  ml  Dulbecco's modified Eagle's  medium  (DMEM),  containing 25  mM 
Hepes (M. A. Bioproducts, Walkersville, MD), 4.5 g/liter glucose, 1 /~g/ml insulin, 0.2% 
fatty acid-free bovine serum albumin (BSA) (Boehringer Mannheim Diagnostics, Inc.). 
After the  first 2  h  of culture, the medium, containing  10%  heat-inactivated fetal calf 
serum, was changed, to remove nonadherent cells. The cells were kept in culture at 37°C 
under a 5% COt, 95% air atmosphere for up to 12 d, with change of medium every day. 
Mouse  IL-1.  Recombinant  mouse  IL-1  (pILI,  1-156;  kindly  provided  by  Dr.  W. 
Benjamin, Hoffman-La Roche, Nutley NJ) with 6 x  108 U/rag sp act (6) and a pI of ~5, 
was stored in 5 M guanidine hydrochloride at -20°C. 
Human IL-I.  Human plateletpheresis byproducts were used as a source of mononu- 
clear cells,  which were adjusted to a  concentration of 107 cells/ml in Eagle's minimum 
essential medium (MEM) without methionine. Cells were incubated at 37°C for 1.5 h in 
medium  containing  1%  dialyzed  human  AB  serum,  and  the  nonadherent  cells  were 
removed by vigorous shaking. The adherent cell population was incubated in MEM, and 
stimulated with opsonized heat-killed Staphylococcus albus. After 36 h, the supernatant was 
removed, centrifuged at  3,000 g,  filtered, and applied to an  immunoadsorbent.  The 
preparation of the  immunoadsorbent,  and the  purification procedures have been de- 
scribed previously (15,  16).  Gel filtration was over Sephadex G-50 (fine),  170 x  5 cm, 
Which had been autoclaved in pyrogen-free water. The chromatofocusing gel was pur- 
chased  from  Pharmacia  Fine  Chemicals  (Piscataway,  NJ),  and  washed  extensively in 
endotoxin-free imidazole buffer. 200 rabbit pyrogen doses were bound to the immunad- 
sorbent at 37°C, and the IL-1 was eluted with two column volumes of 0.1  M citric acid 
buffer, pH  2.5, containing  100 ~.g/ml  BSA. The eluted material was collected in  10% 
lysine (final concentration  1%) and immediately neutralized with  NaOH. IL-1 assay of 
both  the  starting  and  eluted  material  revealed  a  recovery of ~75%.  The  IL-1  was 932  INTERLEUKIN  1  MODULATION  OF  ACUTE  PHASE  PROTEINS 
concentrated to  1/20 volume in autoclaved dialysis tubing (cutoff, 3.5 kilodaltons [kD]) 
against polyethylene glycol (8-10  kD), and applied to Sephadex G-50 in  0.15  M  NaCI 
containing  100  #g/ml  BSA.  Each  fraction was assayed for IL-1, and  the  peak of IL-1 
activity, eluting at 15-20 kD, was pooled, concentrated, dialyzed against 0.1  M imidazole 
buffer, pH 7.8. The dialyzed IL-1 peak was then applied to a chromatofocusing gel, and 
washed with two column volumes of imidazole buffer followed by polybuffer 94 (Phar- 
macia Fine Chemicals), to generate a pH gradient between 7.6 and 4.5. Each fraction was 
assayed for IL-1 (17), and the neutral pI peak (Fig.  1) was isolated (sp act ~6 ×  106 U/mg 
protein) and used. 
Before addition to the hepatocyte cultures, both human and mouse IL-1 preparations 
were adjusted to the appropriate concentration by dilution in culture medium containing 
2 mg/ml BSA, followed by filtration through a 0.45 #m Millipore filter. Control solution 
for human IL-1 contained the appropriate dilution of 1% BSA in saline. Control solutions 
for mouse IL-1 contained guanidine hydrochloride or nontransformed bacterial extract 
in the same concentration as that of the highest IL-1 concentration. 
Antisera.  Rabbit antiserum to mouse albumin was purchased from Miles Laboratories, 
Inc. (Elkhart, IN). IgG containing anti-human factor B that crossreacts with mouse factor 
B was purchased from Atlantic Antibodies (Scarborough, ME). SAA was precipitated with 
rabbit antibodies raised against mouse AA (amyloid A) protein, according to the method 
of Linke et al. (18).  For immunoprecipitation, the antiserum was adsorbed with normal 
mouse serum in  which  no SAA was detectable by radioimmunoassay. For radioimmu- 
noassay, the anti-AA antibodies  were concentrated and  purified on an affinity column 
(18). 
Immunoprecipitation of  Radiolabeled Proteins.  Radiolabeling, immunoprecipitation, and 
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were performed 
as previously described (19).  Briefly, hepatocyte monolayers (Linbro plates) were pulsed 
for a suitable interval with methionine-free DMEM containing 800 #Ci/ml [sSS]methionine 
(sp act  1,000  #Ci/mmol) (New England  Nuclear,  Boston,  MA). Total protein synthesis 
was measured by trichloroacetic acid (TCA) precipitation of 1 #1 of cellular iysates, and 
of supernatants (20) obtained as follows. The cells were washed on ice with cold Hank's 
balanced salt solution (HBSS), and lysed by freeze-thawing with a solution of phosphate- 
buffered saline,  pH 7.5,  containing  100  mM  KC1, 1%  Triton  X  100  (Sigma Chemical 
Co.),  0.5%  sodium  deoxycholate (Sigma Chemical  Co.),  2  mM  phenylmethylsulphonyl 
fluoride  (Sigma  Chemical  Co.),  10  mM  EDTA,  and  100  #g/ml  Leupeptin  (Protein 
Research Foundation,  Oszka, Japan). The culture supernatants and lysates were centri- 
FIGURE  1.  SDS-PAGE autoradiograph  of purified human IL-1. For analytical purposes, an 
aliquot of the monokine was labelled with [~SS]methionine, and carried through the purification 
procedure.  Fractions  from the final chromato-focusing  separation  were analyzed by SDS- 
PAGE (17.5 % acrylamide, 1 mM 2-mercaptoethanol,  10 m  M Tris, pH 7.2) and fluorograpby. 
The biological activity of a  1:200 dilution of each fraction was measured by the thymocyte 
assay. Fractions 1-7 correspond to pH 7.5, 7.4, 7.19, 6.99, 6.65, 6.3, 6.03, and peak thymocyte 
stimulation was found in fraction 5. We used a pool of fractions 3-6. RAMADORI  ET  AL.  933 
fuged in a Eppendorf minifuge for 30 min at 4°C, diluted with the lysis buffer containing 
1% SDS, and stored at -90°C. The balance of the procedure was carried out exactly as 
described by Auerbach et al. (19). 
Isolation of RNA.  Hepatocyte monolayers in six-well Falcon plates were washed three 
times with HBSS, then lysed with 3  mi of 4  M  guanidinium thiocyanate (Fluka A.  G. 
Buchs, Basel,  Switzerland), 25 mM sodium citrate, and 0.5% sodium-N-iaurylsarcosinate 
(K and L Laboratories, Inc., Plainview, NY) (22). The cells were detached from the dish 
with a rubber policeman, and the DNA was sheared by repeated passage through a 23- 
gauge needle. The guanidinium lysate was then layered onto 2 ml of 5.7 M  CsCI in a 
Beckman SW 50.1 rotor (Beckman Instruments, Inc., Fullerton, CA) for 17 h at 35,000 
rpm at 20°C; the RNA pellet was washed twice in ethanol, then dissolved in water and 
reprecipitated in ethanol (15 rain in dry ice/ethanol bath, or at -20 °C overnight), and 
dissolved in water. RNA content was determined by measurement of absorption at 260 
nm. Yields were in the range of 35-40 gg RNA/10o cells. 
RNA  was  extracted from whole liver, either by phenol/chloroform/isoamyl alcohol 
extraction (23) after homogenization of tissue, or from liver frozen in liquid nitrogen and 
then extracted with 4 M guanidinium thyocyanate (1:10 vol/vol), followed by uitracen- 
trifugation as described above (22). 
cDNA Clones and Northern Blot Analysis.  The factor B cDNA clone pBmB2 employed 
in this study has been described elsewhere (8). It is 1.5 kilobases (kb) long, and spans 94% 
of the protein sequence for the murine Bb fragment. The SAA-specific cDNA (9) clone 
pAla,  which contains the coding sequence for amino acid  residues -10-55  of human 
apoSAAL-a was  subcloned into ), phage M13 mp  11.  The nucleotide sequence of the 
cDNA coding for amino residues 33-45 is identical to that coding for the corresponding 
constant region peptide of mouse SAA (9, 24). Mouse albumin cDNA (7) was a gift of Dr. 
S. Tilghman (Cancer Research Institute, Philadelphia, PA). 
Chicken a-actin cDNA, which also hyridizes with/3- and 7-actin (25), was kindly provided 
by R. J. Schwartz (Baylor College of Medicine, Houston, TX). Whereas factor B-, albu- 
min-, and actin-specific cDNA were s2p labelled by nick translation, radiolabeled SAA- 
specific single-stranded cDNA was prepared by primed synthesis with [3~P]dNTP (New 
England Nuclear), and by extension using the Klenow DNA polymerase large fragment 
(Boehringer Mannheim Diagnostics, Inc.) after hybridization of the M13 template with 
the universal primer (New England  Biolabs,  Boston, MA).  The free nucleotides were 
removed by two spin dialyses.  Detection of specific mRNA by Northern blot hybridization 
was accomplished using reagents and methods exactly as previously described (26). 
SAA Measurements.  SAA  concentration was  measured in  serum  obtained from the 
orbital plexus, an aliquot of which was heated at 60°C for 1 h. Several dilutions were 
analyzed in triplicate by the competitive binding radioimmunoassay, as described previ- 
ously (27). 
Results 
Recombinant  IL-1  Regulates SAA  Gene Expression  in  Vivo.  Recombinant-gen- 
erated purified murine  IL-1  was injected intravenously into C3H/HeJ  mice at 
doses  of  500  and  1,000  U/mouse.  SAA  gene  expression  was  monitored  by 
Northern  blot  analysis  of  liver  mRNA  and  SAA  protein  concentration  was 
estimated in sera obtained from individual mice at timed intervals. The concen- 
tration of hepatic SAA-specific mRNA increased within 2 h after IL-1 injection, 
peaked at  4  h  postinjection, and  remained  elevated above baseline after  12  h 
(Fig. 2A). Similar kinetics were observed for both IL-1 doses, but the magnitude 
of the effect was dose dependent.  A  dose-dependent increase in serum concen- 
tration of the SAA protein after IL-1  injection was first detectable at 4  h  (the 
peak response),  after which concentrations declined  to  15  #g/ml at  12  h  (Fig. 
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FIGURE 2.  A, Northern blot analysis of SAA mRNA in C3H/HeJ mice after injection of 500 
U  recombinant IL-1.  Each lane contains 15 #g of RNA extracted with guanidinium isothio- 
cyanate. 1, RNA extracted 4 h after intravenous injection of nontransformed bacterial extract. 
2-5, RNA extracted 2, 4, 6, and 12 h after injection of mouse recombinant IL-1. Hybridization 
with s~p-radiolabeled SAA cDNA  was performed as described in Material and Methods. B, 
serum concentration of SAA after intravenous injection of recombinant mouse IL-1.  SAA 
levels were measured in serum samples taken at different intervals after intravenous injection 
of 1,000 U  IL-1 (O), U IL-1 (O), or nontransformed bacterial extract (A) into C3H/HeJ mice. 
Controls included animals  injected intravenously with an extract of nontrans- 
formed bacteria dissolved in 5 M guanidine hydrochloride (bacterial extract) or 
with the guanidine  solution alone, each at an appropriate  dilution in 250 #1 of 
pyrogen-free saline.  No SAA protein was detected in sera of nine control mice, 
and only a  small amount of specific RNA was detected in livers of two of five 
control animals (Fig. 2,A1). 
Protein Biosynthesis in Hepatocytes as a Function of Time in Culture.  Hepatocyte 
monolayers in replicate dishes were examined at timed intervals,  from  1.5 h  to 
10 d  in culture, for specific mRNA content and protein synthesis. Total protein 
synthesis (TCA-precipitable  radioactivity) decreased from 250,000 cpm in 5  ttl 
on day 1, to 70% of the initial value by day 5, then gradually increased again up 
to 220,000 cpm in 5 ttl by day 8, and declined again thereafter.  Normal  liver, 
and  unstimulated  hepatocytes  at  1.5  h  in  culture  generally  did  not  contain 
detectable SAA mRNA,  but a  spontaneous increase  in SAA mRNA and  SAA 
synthesis was noted in cells at day  1 and  2, regardless  of whether liver from a 
lipopolysaccharide responder  (C3HeB/FeJ) or nonresponder  (C3H/HeJ) strain 
was used (Fig. 3A). After day 2 in culture, baseline synthesis of SAA protein and 
SAA  mRNA  were  low  or  undetectable.  Factor  B  mRNA  was  also  relatively 
abundant on days 1 and 2, decreased, then increased to a second peak on day 8 
in culture.  At all time points tested between day 3  and  8,  mouse recombinant 
IL-1  or human  IL-1  induced significant increases in SAA-specific mRNA (Fig. 
3B) and protein synthesis.  A  similar but less pronounced  effect of IL-1  on the 
induction  of factor  B-specific mRNA and  protein  synthesis was noted.  In  the 
cultures fed with medium alone, albumin  synthesis was maintained  for at least 
10 d in culture.  Because of the changes in baseline gene expression with time in 
culture,  the maximal  IL-l-mediated  effect on SAA factor B and albumin  gene 
expression  was  observed  after  day  3,  therefore  all  subsequent  studies  were 
performed using cells from day 4-9 in culture. 
Kinetics  of IL-1 Action  on Hepatocytes in Tissue  Culture.  The amount  of time 
required for IL-1  to effect changes in SAA, factor B, and albumin gene expres- RAMADORI  ET  AL.  9:35 
FIGURE 3.  A,  Northern blot analysis of RNA  samples extracted from  C3HeB/FeJ  mouse 
hepatocytes cultured for a  10-d period. Aliquots of liver RNA from each day were electropho- 
resed, transferred, and probed with s2p-labeled SAA and factor B cDNA.  B,  Northern blot 
analysis of RNA  extracted  from hepatocytes isolated from  a  C3H/HeJ  mouse and kept in 
culture for varying times, up to 8 d.  I, hepatocytes cultured for 2 d, then incubated for 20 h 
with medium containing bacterial extract.  2,  2-d cultures incubated for 20 h  with medium 
containing 200 U/ml of mouse recombinant I L-1.3, 8-d cultures incubated for 20 h with 200 
U/ml of mouse IL-1.4, 8-d culture incubated for 20 h with medium containing nontransformed 
bacterial extract. 5, liver RNA from a C3HeB/FeJ mouse 16 h after intraperitoneal injection 
of 10 ~g endotoxin (Salmonella typhosa W, purchased from Difco Laboratories, Detroit, MI), 
and used as positive control. 6, liver RNA from C3HeB/FeJ (control) injected with saline, s~p_ 
labeled factor B and SAA cDNA were used as probes. 
sion was monitored by Northern blot analysis and immunoprecipitation of newly 
synthesized protein.  Hepatocytes were incubated with IL-1 at intervals up to 24 
h, and were then  either pulsed for 2  h  with [~SS]methionine,  or were lysed for 
RNA extraction.  IL-l°induced  inhibition  of albumin  synthesis  was  detectable 
(Fig.  4,A)  within  2  h,  and  progressively decreased up to  24  h,  the end  of the 
observation period.  A  corresponding decrease in the albumin  mRNA level was 936  INTERLEUKIN  1  MODULATION  OF  ACUTE  PHASE  PROTEINS 
FIGURE 4.  Kinetics of mouse  recombinant  IL-1  inhibition of (A) albumin  synthesis  and 
kinetics of release, from (B) the IL-1  effect. SDS-PAGE (7.5%)  of secreted [sSS]methionine- 
labeled albumin immunoprecipitated from media of hepatocyte cultures after preincubation 
with mouse IL-1 (100  U/ml). A  1, control (medium alone); 2, recombinant IL-1 during the 2- 
h  pulse-labelling period; 3,  after 3  h;  4,  after 7  h;  5,  after  12  h; and  6,  after  24  h  with 
recombinant  IL-1.  B,  7,  hepatocytes were  pulse-labeled for  2  h,  4  h  after  washing  out 
recombinant IL-1; 8, control (no 1L-1 preincubation); 9,  10 h after release from recombinant 
IL-1; I0,  10-h control; I1, 22 h after release from IL-1; 12, 22-h control. 
FIGURE 5.  Kinetics of mouse IL-1 effect on hepatocyte albumin and actin mRNA content. 
Northern blot analysis of albumin and actin mRNA. RNA was extracted from 8-d cultures of 
C3H/HeJ hepatocytes. The controls were incubated for 24 h with medium alone (1), or with 
medium containing nontransformed bacterial extract (2). 100 U/ml mouse recombinant IL-1 
for 3 h (3); 7 h (4); 12 h (5), or 24 h (6). 
also detectable, but not until after 3 h, and continued to decrease in the presence 
of IL-1 up to 24 h  (Fig. 5). Increases in SAA and factor B mRNA  were detectable 
by 3  h, and continued to rise up to 24 h  (data not shown). Total protein synthesis 
remained  constant throughout  the observation period. 
The  kinetics of release  from  the  effect  of IL-1  was  studied  in  the  following 
way. Cells were incubated with IL-1  for 20 h, washed thoroughly, and incubated 
for varying lengths of time with medium  lacking IL-1, after which  the cultures RAMADOR1  ET  AL.  937 
FIGURE 6.  A, dose-response regulation of factor B, albumin and SAA synthesis by hepatocytes 
in culture. SDS-PAGE (7.5% for albumin and factor B,  15%  for SAA) of extracellular factor 
B, albumin, and SAA immunoprecipitated from hepatocyte culture media, after a  2-h pulse 
with [sSS]methionine.  Lanes  1-4,  0.5,  2.5,  5.0, and  10  U/ml human  IL-1,  lane 5,  negative 
control (medium lacking human IL-1), 6 and 7,  10, and 40 U/ml of mouse recombinant IL-1, 
respectively. B,  factor  B,  albumin,  and  SAA biosynthesis  by  hepatocytes  in  culture;  dose- 
response to mouse recombinant IL-1. SDS-PAGE (7.5%  for albumin and for factor B,  15% 
for SAA) of intracellular factor B, albumin, and SAA immunoprecipitated from cellular lysates 
after 22-h pulse with [sSS]methionine. Lane  1, hepatocytes incubated with medium alone; 2- 
4, hepatocytes incubated with medium containing 5, 20,  100 U/ml mouse recombinant IL-1; 
5, 30 U/ml human IL-1; 6, nontransformed bacterial extract; 7, medium containing dilution 
of guanidine hydrochloride; 8, medium containing 10 #g LPS/ml. Film exposed 2 d for factor 
B,  24  h  for albumin,  and  21  d  for  SAA.  The  triplet  of intracellular  factor  B  represents 
different stages of glycosylation of the molecule. 
were pulse-labeled  for  2  h  with  [SSS]methionine.  Reversal  of the  inhibition  of 
albumin synthesis was detectable  12 h after removal of IL-1  , reaching baseline 
levels by 24 h (Fig. 4B), whereas increased SAA synthesis above baseline was still 
detectable 24 h after removing IL-1  (data not shown). 
Dose-response Effect of  Mouse and Human IL-1.  Changes in SAA, factor B, and 
albumin synthesis were dependent on  the concentration  of either recombinant 
mouse IL-1  or purified human  monocyte IL-1  present in the culture medium. 
The effect on these proteins (assessed after 20 h) was detectable at 0.5-10  U/ml 
in the case of both  the human  and  mouse  monokines (Fig.  6,AandB),  both at 
the protein level and at the mRNA level (Fig. 7). The changes in factor B mRNA 
was  significant,  but  the  magnitude  of this  change  was  less  than  the  relative 
increase  in  SAA  mRNA.  No  significant  effect  was  seen  when  the  cells  were 938  INTERLEUKIN  1  MODULATION  OF  ACUTE  PHASE  PROTEINS 
FIGURE 7.  Northern blot analysis of actin, albumin, factor B, and SAA mRNA in hepatocyte 
cultures; dose-response to mouse recombinant IL-1. RNA extracted from C3H/HeJ hepato- 
cytes isolated and  cultured  for  8  d,  then  incubated  for 20  h  with varying doses of mouse 
recombinant IL-1. 1, control (nontransformed bacterial extract in guanidine hydrochloride); 
2, 20 U/ml; 3,  100 U/ml; 4, 200 U/ml; 5, 400 U/ml. 3~P-labeled probes specific for albumin, 
factor B, SAA, and for actin were used for hybridization. Soft-laser densitometry of the factor 
B signal showed an increase in specific message of approximately twofold with 100 U IL-1. 
incubated with the nontransformed bacterial extract or with 10 #g/ml LPS (Fig. 
6B). There  was no effect of IL-1  on expression of the actin  gene at any dose 
examined (Fig. 7). 
The  specificity of the  observed  effects of IL-1  was  confirmed  by blocking 
experiments with goat anti-mouse IL-1 (28) (data not shown) in which inhibition 
of albumin  synthesis  induced  by  50  U/ml  of  recombinant  mouse  IL-1  was 
reversed by the presence of the antibody. 
Discussion 
Previous studies (29-34) of the response to tissue injury or acute inflammation 
strongly  suggested  that  the  monokine  IL-1  was an  important  mediator  of the 
characteristic  changes  in plasma  protein  concentration.  We provide direct  evi- 
dence  that  recombinant-generated  IL-1  increases  expression  of the  genes  for 
SAA and  factor B,  two positive acute phase  reactants,  and  the same mediator 
decreases expression  of the albumin  gene,  the product  of which  is a  negative 
acute  phase  protein.  The  fact that  IL-1  has opposite effects on  expression  of RAMADORI  ET  AL.  939 
albumin and the other two genes indicates that either transduction of the signal 
from IL-1 receptor to the hepatocyte nucleus is transmitted by multiple mecha- 
nisms, or that the regulatory sequences for the positive and negative acute phase 
genes respond differentially to  the same signal.  Recombinant-generated IL-1 
induced these changes when injected intravenously into mice of the endotoxin- 
resistant  strain,  C3H/HeJ,  and  in  primary murine hepatocyte cultures.  This 
finding, and the lack of response to a control bacterial extract or to endotoxin 
in tissue culture ruled out the possibility that endotoxin contamination of the 
recombinant-generated IL-1  preparation was responsible for the effector func- 
tion. 
Parallel changes in protein synthesis and specific mRNA levels establish that 
both the positive (SAA and factor B) and negative (albumin) regulatory effects 
of IL-1 on hepatic gene expression are pretranslational. Though it is likely that 
changes in transcription rates account for these changes in mRNA levels, there 
is, as yet, not direct evidence for this conclusion. 
Selection of the optimum culture conditions for liver cells permitted a detailed 
study of the kinetics and dose-response to IL-1  in preparations containing 99% 
hepatocytes. That  is,  low baseline levels of constitutive SAA gene expression 
permit substantial regulation by IL-1  (i.e., maximal signal-to-background). The 
IL-1 response is rapid in onset (<7 h), and relatively long lasting (>24 h), but is 
reversible for each of the genes studied when IL-1  is removed. Finally, highly 
purified human IL-1  had similar effects on SAA, factor B,  and albumin gene 
expression. This is of interest because previous reports (6, 35) showed primary 
structural  differences between  the  murine and  human  IL-1  polypeptides  se- 
quenced thus far. 
Each of the genes studied here, and other IL-l-responsive genes, such as IL-2 
(36), have been cloned. Detailed structural information is therefore available for 
each. A comparison of potential regulatory sequences among these genes will be 
useful for further defining the mechanisms regulating the response to inflam- 
mation.  For some genes,  stable  transfected cells in  which the cloned gene is 
expressed have been generated (36-38),  allowing further investigation of the 
structural requirements for IL-1 responsiveness. 
Others  (39)  have  suggested  that  a  factor  distinct  from  IL-1,  namely the 
hepatocyte-stimulating factor (HSF), effects changes in synthesis of fibrinogen. 
HSF is less  well-defined than either of the two IL-1  preparations used in this 
study.  However, the possibility that other mediators in addition  to  IL-1  may 
regulate expression of SAA, factor B, and albumin genes in hepatocytes is not 
excluded. 
Summary 
During the acute phase response to tissue injury or inflammation, the concen- 
tration of several plasma proteins change. Previous work (29-34)  suggested a 
role for interleukin  1  (IL-1)  in  the acute phase  response.  The availability of 
recombinant-generated mouse IL-1  prompted a  study designed to directly test 
the function of IL-1  and its  mechanism of action on hepatic synthesis of two 
positive acute phase proteins (serum amyloid A  [SAA] and complement factor 
B),  and  a  negative  acute  phase  reactant  (albumin).  Intravenous  injection  of 940  INTERLEUKIN  1 MODULATION  OF  ACUTE  PHASE PROTEINS 
purified recombinant-generated murine-IL-1  into C3H/HeJ endotoxin-resistant 
mice induced a dose-dependent increase in SAA-specific hepatic messenger RNA 
(mRNA),  and  an  increase  in  SAA  plasma  protein  concentration.  In  primary 
murine  hepatocyte  cultures,  both  the  recombinant  IL-1  and  highly  purified 
human IL-1 induced a dose-and time-dependent, reversible increase in expres- 
sion of the SAA and factor B genes, and a decrease in albumin gene expression. 
This regulation is pretranslational, since the kinetics and direction of change in 
specific mRNA  for SAA,  factor B, and albumin  correspond to the changes  in 
synthesis of the respective proteins.  Moreover, the effect of IL-1  was  specific, 
since actin gene expression was unaffected, and the IL-1 response was inhibited 
by antibody specific for IL-1. These data provide direct evidence that a  single 
mediator,  IL-1, can effect the positive and negative changes in specific hepatic 
gene expression characteristic of the acute phase response. 
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